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Abstract 
Background: Premature ovarian failure (POF) is a disorder of multi causal etiology. Autoimmunity 
has been proposed as a mechanism for some cases of ovarian follicle dysfunction which is evident 
in POF. The aim of this study was to identify the level of auto-antibodies in POF and familial POF 
patients.
Materials and Methods: In this study, auto-antibodies including anti-ovarian antibody (AOA), 
anti thyroid peroxidase (TPO) and anti thyroglobulin (TG) antibodies were assessed in the sera of 
43 cases with spontaneous POF including 12 cases affected by familial POF. The control samples 
were obtained from sera of 39 women with normal ovulatory or post menopause women.
Results: AOA were detected in 46.5% of the POF group, 41.7% of the familial POF group and 41% 
of the control group without significant statistical difference between the three groups. Thyroid 
peroxidase (TPO) antibody was found in 32.6% of the POF group, 41.6% of the familial POF group 
and 10.3% of the control group. Anti TPO was detected significantly high in both POF and familial 
POF groups (p<0.02 and p<0.01, respectively). Thyroglobulin (TG) antibody was found in 48.8% 
of the POF group, 75% of the familial POF group and 23.1% of the control group with meaningful 
difference (p<0.02 and p<0.001, respectively). TG antibody was significantly higher in familial 
POF group in comparison to POF group (p<0.03).
Conclusion: Although measurement of AOA is not a reliable method for diagnosis of auto-immune 
POF, but existence of anti thyroid antibodies in familial POF (mainly anti TG) can potentially 
represent an autoimmune mechanism. It is possible to propose a genetic component for developing 
autoimmune POF supported by presence of anti thyroid antibodies in familial POF.




Premature ovarian failure (POF) is a non physiological 
cessation of menstrual cycle before the age of 40 years 
and after puberty (hence, in fact, secondary amenor-
rhea) (1). Women with POF have a hyper gonadotropic- 
hypoestrogenic hormone profile (2, 3). POF is a het-
erogeneous disorder with a multi causal pathogenesis. 
Chromosomal (4), genetic (5), enzymatic (6), iatrogenic 
(7) or infectious (8) factors may all form the basis for 
the disappearance of ovarian follicles (2). 
A large proportion of women with primary ovarian fail-
ure have no identified causes .The etiology of POF can 
be divided into two broad categories: ovarian follicle 
depletion and ovarian follicle dysfunction .Ovarian au-
toimmunity is a possible cause of both afollicular and 
follicular forms of POF and both follicle depletion and 
dysfunction occur (2, 9). 
POF is frequently associated with autoimmune disor-
ders, particularly autoimmune thyroid disease. In the 
absence of clinically overt disease, some patients have 
serological evidence of autoimmunity mainly against 
thyroid (10). These observations suggest that autoim-
munity may be an important cause of idiopathic POF. 
Using microsomal ovarian antibodies and oocyte anti-
bodies, an autoimmune basis was detected in as many 
as 69% of women (11). The aim of this study was to 









anti TG antibodies in the POF and familial POF cases in 
comparison to the control group. 
Materials and Methods
This case control study was performed between 2004 
and 2005. Sera from 43 women with spontaneous POF 
(12 cases with familial POF) were assessed for the pres-
ence of AOA, anti TPO and anti TG antibodies. These 
cases referred sequentially to Royan institute and gyne-
cology clinic in Taleghani teaching hospital affiliated 
to Shahid Beheshti University of Medical Sciences in 
Tehran, Iran. All patients in case group had cessations of 
menstrual cycles before the age of 40 in association with 
raised serum levels of FSH more than 10 IU/ml (12). All 
of cases had secondary amenorrhea. Familial POF was 
defined as existence of POF in the first or second degree 
relatives. 
The control group consisted of 39 women including 
31 women with normal ovulation referred for choos-
ing some contraceptive methods and the other 8 women 
were in post menopausal period.
The project was approved by Royan Institute ethics 
committee. All cases and controls signed the consent 
form. None of them had clinical evidence of autoim-
mune disease. All laboratory tests were done in the labo-
ratory of Royan Institute. 
Inclusion criteria included: spontaneous cessation of 
menstrual cycle before 40 year with secondary amenor-
rhea. Exclusion criteria were surgical menopause or POF 
due to chemotherapy or radiotherapy. Neither cases nor 
control had overt autoimmune disease. None of the cas-
es and controls had familial relationship with each other. 
SPSS version 13 was used for data entry. The chi-square 
test on 2×2 contingency tables was used for statistical 
analysis. The subjects were screened for immunological 
markers associated with autoimmune disease including 
anti TPO, TG, AOA and also were evaluated for some 
related hormonal and biochemical agents such as FSH, 
LH, Prolactin, TSH.
Blood samples were allowed to clot; sera were separated 
by centrifugation and stored at -20°C until assayed. The 
subjects were assessed for the presence of auto-antibod-
ies raised against thyroid (anti TPO and TG antibodies) 
and ovaries (AOA) by using ELISA method. Values 
were equal or greater than 10 IU for AOA, 75 IU for anti 
TPO and 100 IU for anti TG considered as positive. 
Serum samples were evaluated for the presence of auto-
antibodies raised against thyroid (Thyroid Peroxidase 
Antibody; ELISA, GENESIS, Cambridge shire CB6 
1SE, UK, anti Thyroglobulin antibody; ELISA, GEN-
ESIS, Cambridge shire CB6 1SE, UK.) and human 
ovarian tissues (Anti-Ovary antibody, ELISA, Bioserv 
Diagnostics, Rostock, Germany). They were also evalu-
ated for measurement of Follicle Stimulating Hormone 
concentration (FSH, IRMA, Pooyesh Tashkhis, Tehran, 
Iran), Luteizing Hormone concentration (LH, IRMA, 
Pooyesh Tashkhis, Tehran, Iran), Prolactin concentra-
tion (PRL, IRMA, Pooyesh Tashkhis, Tehran, Iran), 
and Thyroid Stimulating Hormone concentration (TSH, 
IRMA, Pooyesh Tashkhis, Tehran, Iran).
Results
In this study, 43 women with POF were compared with 
39 women as the control group. Mean age of patients in 
POF group was 27.87±3.1 (15-39 year). Mean values of 
FSH were 71.24±9.42 for the POF group and 6.8±0.63 
IU for the control group. TSH and Prolactin levels were 
within normal limits in both groups.
ELISA for anti-ovarian antibody revealed that 46.5% 
of the POF group (20 out of 43), 41.7% of the familial 
POF group (5 out of 12) and 41% of the control group 
(16 out of 39 patients) had AOA .
The difference between the case and control groups 
were not statistical meaningful. The POF group was 
divided into two subgroups based on the onset of POF 
(before or after the age of 25 year). Non-parametric test 
of Mann-Whitney did not show any difference in exist-
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Fig 1: Bar graph of AOA level distribution in the studied groups
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Table 1: Auto-antibodies in POF and control groups
Auto-antibody POF cases Controls Risk Ratio Confidence 
Interval (%95)
P Value
AOA 46.5% 41.0% 1.250(0.521-3.000) 0.617
anti TG 48.8% 23.1% 3.182(1.224 -8.270) *0.02
anti TPO 32.6% 10.3% 4.224(1.253-14.241) *0.02

































































Fig 3: Bar graph of anti TG level distribution in the studied groups
Anti TPO antibody was detected in 32.6% of the POF 
group, 41.7% of the familial POF group and 10.3% of 
the control group .The difference between the POF and 
familial POF groups was statistically significant com-
pared to the control group (p<0.02 and p<0.01, respec-
tively). 
Anti TG was found in 48.8% of the POF group, 77.5% 
in the familial POF group and 23.1% of the control 
group. There was significantly higher positive anti TG 
in the POF and familial POF groups compared to the 
control group; (p<0.02 and p<0.001, respectively). 
Anti TG antibody was detected more prevalent in 
the familial POF group compared to the POF group 
(p<0.03).The results are shown in the tables 1-3 and 
figures 1-3. 
Discussion
Since fluorescent method has less specificity and sensi-
tivity than ELISA (13), ELISA was used for the present 
study. Autoimmune POF has been considered to be a 
mechanism possibly responsible for primary idiopathic 
POF. Several studies revealed the association of AOA 
with POF. The incidence of AOA in patients with POF 
ranges widely (20-67%), according to the type of anti-
body, methods used for selection of patients and meas-
urement of auto antibodies (14, 15).
It is possible that AOA has cross reaction with other tis-
sues. Although one specific antigen is not determined, 
several antigens must be considered (14).
It is suggested that initiation of autoimmune process 
and production of AOA is secondary to every procedure 
causing invasion to ovaries such as IVF, ovarian biopsy 
or puncture and other mechanical procedures, although 
this trauma is unknown in primary POF (14). 
Although there are evidences against autoimmune 
pathogenesis of POF because oophoritis or inflamma-
Auto Antibodies and POF
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Table 2: Auto-antibodies in POF and Familial POF





Risk Ratio Confidence 
Interval (%95)
P Value
AOA 41.7% 48.4% 0.762(0.198-2.929) 0.69
anti TG 75% 38.7% 4.750(1.067-21.144) *0.03
anti TPO 41.7% 29% 1.746(0.437-6.976) 0.43
Auto antibodies 75% 71% 1.227(0.269-5.608) 0.79
* Significant Difference
Table 3 . Auto-antibodies in Familial POF and Control groups
Auto antibodies Familial 
POF
Controls Risk Ratio Confidence 
Interval (%95)
P Value
AOA 41.7% 41% 1.027(0.276-3.817) 0.97
anti TG 75% 23.1% 10.000(2.222-44.999) *0.001
anti TPO 41.7% 10.3% 6.250(1.333-29.301) *0.01










tion of ovaries is not seen in all cases of POF (it is seen 
only in less than 3%); in animal models being immu-
nized against zona plucida, reduction of ovarian folli-
cles and fibrosis (similarly to POF) are reported (2).
Massin et al (16) evaluated presence of ovarian follicles 
in POF patients by biopsy .Their results showed that 
ovarian follicles more than 2 mm were seen in 56% of 
POF patients. In present study, ovarian biopsy was not 
done because of its invasive nature.
Conclusion
AOA was not a suitable marker for diagnosis of POF in 
our study, but thyroid auto-antibodies such as anti TPO 
and especially anti TG were detected more significantly 
in POF cases. Findings of our study revealed we need 
to detect some specific auto-antibodies except AOA and 
anti ZP antibodies for diagnosis of POF.
Presence of antithyroid antibodies in our study shows 
that in POF cases, one should consider other endocrin-
opathies not limited to ovary, like involvement of thy-
roid.
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